Shenglin Ma

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 04, 2023
KEYNOTE-033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD-L1-positive, advanced NSCLC.

Shengxiang Ren, Jifeng Feng, Shenglin Ma

Pageof 1

Frequent Collaborators

1 joint publications

Caicun Zhou